TGFBR2 and colorectal carcinoma: The reduction or loss of TGFBR2 expression enables cancer cells to escape the growth inhibitory effect of TGF-β and to gain a proliferative advantage, and the downregulation of TGFBR2 is a frequent event in early-stage CRC.